Valuation
- Market cap
- 134,584,000
- Revenue TTM
- $41,130,000
- Net income TTM
- $-2,640,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- -6.42%
- Debt to equity
- 0.00
Trading
- Volume
- 280,800
- Avg volume
- 257,394
- Day's range
- $2.86 – $3.04
- Shares out
- 45,933,000
- Stochastic %K
- 30%
- Beta
- 0.43
- Analysts
- Strong Sell
- Price target
- $6.25
Company profile
KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary i...
Show more
KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 Syringe Driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.
- Industry
- Medical Instruments & Supplies
- Sector
- Healthcare
- Phone
- 845 469 2042
- Website
- https://www.korumedical.com
- Address
- 100 Corporate Drive, Mahwah, United States
Latest news
No headlines yet.
